Jain Global’s Nuvectis Pharma NVCT Stock Holding History

Jain Global’s Portfolio NVCT Stock Details NVCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-10,154	Closed	-$99.2K	–	1496
2025 Q1	$99.2K	Buy	+10,154	New	+$73.1K	﹤0.01%	969

Other funds holding NVCT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

BWP

Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

JMFC

J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Jain Global's NVCT Position: Q2 2025 in Review

Jain Global sold out of Nuvectis Pharma (NVCT) in Q2 2025, closing a stake of 10,154 shares — an estimated $99.2K sold.

Jain Global first reported a position in NVCT in Q1 2025 and held it in 1 quarter. The position peaked at $99.2K in Q1 2025. 47 funds tracked by Wall St. Rank hold NVCT as of Q2 2025.

Jain Global reported no remaining Nuvectis Pharma position as of Q2 2025 after selling out during the quarter.
Jain Global sold 10,154 Nuvectis Pharma shares in Q2 2025, an estimated $99.2K.
Jain Global first reported a position in Nuvectis Pharma in Q1 2025 and held it in 1 quarter.
Jain Global's Nuvectis Pharma position peaked at $99.2K in Q1 2025.
47 funds tracked by Wall St. Rank held Nuvectis Pharma as of Q2 2025.

Based on Jain Global's 13F filing for Q2 2025, filed 14 Aug 2025.